跳至主要内容
临床试验/NCT03258697
NCT03258697已完成不适用

The Pharmacokinetics and Effectiveness of Different Methods of Local LevoBupivacaine Injection, a Prospective Randomized Case Control Clinical Study on Primary Total Joint Replacement Model.

Chang Gung Memorial Hospital1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2017年10月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Dosage of analgesic opioid agent

研究概览

简要总结

Total joint replacement is an ideal procedure to treat end stage joint disease. Good post-op pain relief could accelerate patient recovery and rehabilitation, and decrease admission days and medical cost. Local injection of LevoBupivacaine is an effective method in post-operative pain control. The effectiveness of local analgesia was noticed clinically. However, thorough studies about the pharmacokinetics of LevoBupivacaine, maintenance of effect, influence of post-operative rehabilitation are not well studied in different way of injection. The purpose of this study is to evaluate and analyze the pharmacokinetics and effect of local Levobupivacaine injection in different ways, the amount of post-operative fentanyl requirement after local injection, time to first fentanyl request, pain score, immediate post-operative function, side effect of analgesic agents, and medical cost, and to improve the quality of total joint replacement post-operative care.

详细描述

Single large dose of LevoBupivacaine had been proved good analgesic effect in total joint replacement surgery. However, the safety was not well studied. For better understanding the effect and safety of local analgesic agent, we choose LevoBupivacaine with different injection way to find out. We divide patient to three groups, for comparing the effectiveness of LevoBupivacaine, and safety of LevoBupivacaine by checking intra-blood concentration. The pre-emptive analgesics and post-operative analgesics were the same as routine protocol in other total joint replacement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Patient blinded, observer blinded study

入排标准

年龄范围
50 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary total joint replacement, no previous open surgery on the same joint
  • Age 50~80 y/o, Pre-operative diagnosis: degenerative osteoarthritis
  • Pre-operative deformity: varus <15°, valgus <15°, flexion contracture <15°.
  • Patients with normal heart function
  • Willing to receive post-operative questionnaire and outpatient clinic follow-up

排除标准

  • Allergy to Patient-Controlled Analgesia or LevoBupivacaine
  • Mental or cognitive illness that couldn't well response to questionnaire
  • American Society Anesthesiologist more than III degree
  • Liver cirrhosis, chronic renal insufficiency, heart disease or arrhythmia, insulin-dependent diabetes mellitus, and previous narcotic abuse history.
  • Not suitable for using patient-controlled analgesia pump by evaluation of anesthesiologist

研究组 & 干预措施

Peri-articular LevoBupivacaine

Active Comparator

Patient had periarticular local analgesic agent, LevoBupivacaine Hydrochloride, during total joint replacement. Patient had baseline Patient-Controlled Analgesia pump.

干预措施: Levobupivacaine Hydrochloride (Drug)

Intra-articular LevoBupivacaine

Experimental

Patient had intra-articular local analgesic agent, LevoBupivacaine Hydrochloride, during total joint replacement. Patient had baseline Patient-Controlled Analgesia pump.

干预措施: Levobupivacaine Hydrochloride (Drug)

结局指标

主要结局

Dosage of analgesic opioid agent

时间窗: post-operative day2

The total dosage of opioid agent after local LevoBupivacaine injection

次要结局

  • Blood concentration of LevoBupivacaine(25min, 90min, and coming morning after LevoBupivacaine injection)

研究者

发起方
Chang Gung Memorial Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验